Myriad Genetics appoints Raj Jampa as new chief technology officer
He will lead technology strategy, modernize infrastructure, and scale AI capabilities to drive growth and enhance customer experience.
See the latest news and media coverage for Myriad. We track all announcements, press releases, and industry mentions in real time, all in one place.
Genetic testing company
myriad.comLast updated
In short: Myriad expanded its genetic testing portfolio and clinical partnerships while navigating significant stock volatility and financial challenges.
He will lead technology strategy, modernize infrastructure, and scale AI capabilities to drive growth and enhance customer experience.
The test combines genomics and AI to guide active surveillance decisions.
Revenue grew 2% to $200.4 million, net loss was $34.1 million, and full-year guidance was reiterated.
The company will release earnings after market close May 5, 2026 and hold a 4:30 pm ET conference call with live webcast and archived replay available.
Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.
Genetic testing company Myriad Genetics (NASDAQ:MYGN) missed Wall Street’s revenue expectations in Q...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 5.9% in the afternoon session after the company announced the launch of its Precis...
Track Myriad and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Myriad and other trending companies.